The Chinese market for CRM devices will experience robust growth through 2024, driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CRM devices in China across a 10-year period.


The use of CRM devices is growing rapidly in China.

How fast are CRM device implantation procedures growing, and for what indications are they being used?

What factors are driving treatment volume growth?

How will the growing use of CRM devices in treating heart failure change device use and competitors' strategies?

How will more advanced CRM devices like leadless pacemakers and S-ICDs impact the market?

Domestic competitors are almost nonexistent in the Chinese CRM market.

Why have domestic manufacturers not made progress in competing with multinationals?

Which companies are planning to enter the CRM market over the forecast period?

What strategies can domestic competitors leverage?

The Chinese CRM device market is characterized by large regional disparities.

Where are the largest regional markets currently?

Where are the fastest-growing regional markets?

What are the drivers in each of the geographic regions?

Table of contents

  • China
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Factors and Developments
      • End-User Insights
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Cardiac Rhythm Management Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Region
      • Competitive Highlights
      • Competitive Landscape
      • Market Shares
      • Market Factors and Developments
    • Pacemaker Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
    • Implantable Cardioverter Defibrillator Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
    • Cardiac Resynchronization Therapy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Erik J. Bracciodieta, MBiotech

Erik J. Bracciodieta is a senior analyst within the Cardiovascular Medtech Insights team, specializing in cardiac rhythm management and structural heart closure device markets, as well as medical device pricing and regulations in Japan. Erik holds a Master's degree in Biotechnology from the University of Toronto. Follow Erik on Twitter: @ErikB_DRG.  


Related Reports

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Latin America (Supplemental)

The Latin American market for CRM devices will experience modest growth through 2026, driven primarily by an aging population, the i...

View Details

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for CRM devices will expand through 2026, driven primarily by an aging population, th...

View Details

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | United States

The mature US CRM device market will remain flat through 2026, striking a balance between flat generator unit sales, rising...

View Details

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Japan

The mature Japanese CRM device market will remain flat through 2026, characterized by low generator unit volume growth, rising

View Details